Your browser doesn't support javascript.
loading
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
Redfors, Björn; Furer, Ariel; Selker, Harry P; Thiele, Holger; Patel, Manesh R; Chen, Shmuel; Udelson, James E; Ohman, E Magnus; Eitel, Ingo; Granger, Christopher B; Maehara, Akiko; Kirtane, Ajay J; Généreux, Philippe; Jenkins, Paul L; Ben-Yehuda, Ori; Stone, Gregg W.
Afiliação
  • Redfors B; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Furer A; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Medical Corps, Israel Defense Forces, Tel Hashomer, Israel; Department of Military Medicine, Hebrew University Hadassah School of Medicine, Jerusalem, Israel.
  • Selker HP; Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.
  • Thiele H; Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany.
  • Patel MR; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
  • Chen S; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.
  • Udelson JE; Division of Cardiology, Tufts Medical Center, Boston, Massachusetts.
  • Ohman EM; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
  • Eitel I; University Heart Center Lübeck, Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine), University Hospital Schleswig-Holstein, Lübeck, Germany; German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany.
  • Granger CB; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
  • Maehara A; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.
  • Kirtane AJ; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.
  • Généreux P; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey; Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada.
  • Jenkins PL; Mary Imogene Bassett Hospital, Cooperstown, New York.
  • Ben-Yehuda O; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Department of Cardiology, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.
  • Stone GW; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: gregg.stone@mountsinai.org.
J Am Coll Cardiol ; 75(15): 1743-1754, 2020 04 21.
Article em En | MEDLINE | ID: mdl-32299585
ABSTRACT

BACKGROUND:

Smoking is a well-established risk factor for ST-segment elevation myocardial infarction (STEMI); however, once STEMI occurs, smoking has been associated with favorable short-term outcomes, an observation termed the "smoker's paradox." It has been postulated that smoking might exert protective effects that could reduce infarct size, a strong independent predictor of worse outcomes after STEMI.

OBJECTIVES:

The purpose of this study was to determine the relationship among smoking, infarct size, microvascular obstruction (MVO), and adverse outcomes after STEMI.

METHODS:

Individual patient-data were pooled from 10 randomized trials of patients with STEMI undergoing primary percutaneous coronary intervention. Infarct size was assessed at median 4 days by either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed tomography. Multivariable analysis was used to assess the relationship between smoking, infarct size, and the 1-year rates of death or heart failure (HF) hospitalization and reinfarction.

RESULTS:

Among 2,564 patients with STEMI, 1,093 (42.6%) were recent smokers. Smokers were 10 years younger and had fewer comorbidities. Infarct size was similar in smokers and nonsmokers (adjusted difference 0.0%; 95% confidence interval [CI] -3.3% to 3.3%; p = 0.99). Nor was the extent of MVO different between smokers and nonsmokers. Smokers had lower crude 1-year rates of all-cause death (1.0% vs. 2.9%; p < 0.001) and death or HF hospitalization (3.3% vs. 5.1%; p = 0.009) with similar rates of reinfarction. After adjustment for age and other risk factors, smokers had a similar 1-year risk of death (adjusted hazard ratio [adjHR] 0.92; 95% CI 0.46 to 1.84) and higher risks of death or HF hospitalization (adjHR 1.49; 95% CI 1.09 to 2.02) as well as reinfarction (adjHR 1.97; 95% CI 1.17 to 3.33).

CONCLUSIONS:

In the present large-scale individual patient-data pooled analysis, recent smoking was unrelated to infarct size or MVO, but was associated with a worse prognosis after primary PCI in STEMI. The smoker's paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fumar / Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fumar / Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia